Imaging synaptic density in the living human brain
The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Abstract
Synaptic density in the living human brain was measured with positron emission tomography and a synaptic vesicle glycoprotein 2A tracer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In vivo imaging of synaptic density is now possible using PET and [ 11 C]UCB-J - a radioligand that binds to the synaptic vesicle protein 2A (SV2A) 41 .”
From Imaging the effect of ketamine on synaptic density (SV2A) in the living brain (2022) · cites this paper as [41]
In the citing paper
“the most common method to quantify synaptic density has been the quantification of pre-(e.g., synaptophysin [9], synapsin [8]) and post-synaptic (e.g., PSD-95 [10]) genes/proteins”
From Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression (2025) · cites this paper as [9]
In the citing paper
“there was also good correlation between SV2A and the “gold standard” pre-synaptic density marker synaptophysin in western blot and confocal microscopy experiments”
From Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression (2025) · cites this paper as [67]
In the citing paper
“Thus, it was decided that SV2A can be used as an alternative to synaptophysin for quantification of synapse density”
From Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression (2025) · cites this paper as [67]
In the citing paper
“quantification of radiotracer binding to SV2A does correlate with measures of synaptic vesicle number [8,9,69,70] and expression of other pre-synaptic proteins classically used in postmortem and in vitro work (e.g., synaptophysin, synapsin).”
From Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression (2025) · cites this paper as [9]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Measurement of protein using bicinchoninic acid
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., & Klenk, D. C. (1985) · Analytical Biochemistry · doi:10.1016/0003-2697(85)90442-7 · Cited by 18,482
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Schizophrenia risk from complex variation of complement component 4
Sekar, A., Bialas, A. R., de Rivera, H., Davis, A., Hammond, T. R., Kamitaki, N., Tooley, K., Presumey, J., Baum, M., Van Doren, V., et al. (2016) · Nature · doi:10.1038/nature16549 · Cited by 2,394
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
Molecular anatomy of a trafficking organelle
Takamori, S., Holt, M., Stenius, K., Lemke, E. A., Grønborg, M., Riedel, D., Urlaub, H., Schenck, S., Brügger, B., Ringler, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.10.030 · Cited by 2,373 · cited 2×
“2 × 10(14) synapses per liter of brain tissue, as reported for the female human brain (42), and two to five SV2A copies per vesicle (31, 36), it can be estimated that there are 154 to 385 vesicles per synapse.”
BackgroundAzevedo, F. A. C., Carvalho, L. R. B., Grinberg, L. T., Farfel, J. M., Ferretti, R. E. L., Leite, R. E. P., Filho, W. J., Lent, R., & Herculano‐Houzel, S. (2009) · Journal of Comparative Neurology · doi:10.1002/cne.21974 · Cited by 2,337
Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands
Innis, R. B., Cunningham, V. J., Delforge, J., Fujita, M., Gjedde, A., Gunn, R. N., Holden, J., Houle, S., Huang, S.-C., Ichise, M., et al. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600493 · Cited by 1,955
Self-citationDecreased Dendritic Spine Density on Prefrontal Cortical Pyramidal Neurons in Schizophrenia
Glantz, L. A., & Lewis, D. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.65 · Cited by 1,636 · cited 1×
“Moreover, regional synaptic changes have been demonstrated in patients with autism (10), depression (11), or schizophrenia (12, 13).”
BackgroundWiedenmann, B., & Franke, W. W. (1985) · Cell · doi:10.1016/s0092-8674(85)80082-9 · Cited by 1,428 · cited 1×
“SYN is themost abundant synaptic vesicle protein (31) and is a widely used marker of synaptic density (32, 33), because it was one of the first characterized (29, 34) and cloned (35) vesicle membrane proteins.”
BackgroundLoss of mTOR-Dependent Macroautophagy Causes Autistic-like Synaptic Pruning Deficits
Tang, G., Gudsnuk, K., Kuo, S.-H., Cotrina, M. L., Rosoklija, G., Sosunov, A., Sonders, M. S., Kanter, E., Castagna, C., Yamamoto, A., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.07.040 · Cited by 1,146
Research works printed but not linked: 1
- 10.1097/01.wcb.0000033967.83623.34 · doi:10.1097/01.wcb.0000033967.83623.34 · Paper page
Cited by
Items 501–592 of 592
Applications of Positron Emission Tomography (PET) in Preclinical Research
Wang, J., & Ni, R. (2025) · Springer eBooks · doi:10.1007/978-3-031-99410-4_15 · Cited by 2
Armony, J., & Vuilleumier, P. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009342919.005
Mapping the Human Emotion Circuits with Positron Emission Tomography
Nummenmaa, L., & Hirvonen, J. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009342919.009
Soleimani‐Meigooni, D. N., & Rabinovici, G. D. (2025) · Cambridge University Press eBooks · doi:10.1017/9781108985055.006
Knudsen, C., Thomsen, M. B., Højgaard, K., Christiansen, S. L., Wiborg, O., Müller, H. K., Landau, A. M., & Elfving, B. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111572
Tuncel, H., Boellaard, R., Coomans, E. M., Hollander-Meeuwsen, M. D., de Vries, E. F. J., Glaudemans, A. W. J. M., Feltes, P. K., García, D. V., Verfaillie, S. C. J., Wolters, E. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19029033
Tuncel, H., Boellaard, R., Coomans, E. M., Hollander-Meeuwsen, M. D., de Vries, E. F. J., Glaudemans, A. W. J. M., Feltes, P. K., García, D. V., Verfaillie, S. C. J., Wolters, E. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19029039
Tuncel, H., Boellaard, R., Coomans, E. M., Hollander-Meeuwsen, M. D., de Vries, E. F. J., Glaudemans, A. W. J. M., Feltes, P. K., García, D. V., Verfaillie, S. C. J., Wolters, E. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19029045
Tuncel, H., Boellaard, R., Coomans, E. M., Hollander-Meeuwsen, M. D., de Vries, E. F. J., Glaudemans, A. W. J. M., Feltes, P. K., García, D. V., Verfaillie, S. C. J., Wolters, E. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19029057
Tuncel, H., Boellaard, R., Coomans, E. M., Hollander-Meeuwsen, M. D., de Vries, E. F. J., Glaudemans, A. W. J. M., Feltes, P. K., García, D. V., Verfaillie, S. C. J., Wolters, E. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19029066
Key, M. C. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/kny8-9361
Tuncel, H., Boellaard, R., Coomans, E. M., Hollander-Meeuwsen, M. D., de Vries, E. F. J., Glaudemans, A. W. J. M., Feltes, P. K., García, D. V., Verfaillie, S. C. J., Wolters, E. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19029024
Tuncel, H., Boellaard, R., Coomans, E. M., Hollander-Meeuwsen, M. D., de Vries, E. F. J., Glaudemans, A. W. J. M., Feltes, P. K., García, D. V., Verfaillie, S. C. J., Wolters, E. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19029018
Tuncel, H., Boellaard, R., Coomans, E. M., Hollander-Meeuwsen, M. D., de Vries, E. F. J., Glaudemans, A. W. J. M., Feltes, P. K., García, D. V., Verfaillie, S. C. J., Wolters, E. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19029051
Rossano, S. M., Toyonaga, T., Bini, J., Nabulsi, N., Ropchan, J. R., Cai, Z., Huang, Y. H., & Carson, R. E. (2022) · Figshare · doi:10.6084/m9.figshare.19703780
Self-citationO’Dell, R. S., Mecca, A. P., Chen, M.-K., Naganawa, M., Toyonaga, T., Lu, Y., Godek, T. A., Harris, J. E., Bartlett, H. H., Banks, E. R., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13525170
Self-citationTuncel, H., Boellaard, R., Coomans, E. M., Hollander-Meeuwsen, M. D., de Vries, E. F. J., Glaudemans, A. W. J. M., Feltes, P. K., García, D. V., Verfaillie, S. C. J., Wolters, E. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19029021
Jensen, K. H. R., Dam, V. H., Ganz, M., Fisher, P. M., Ip, C.-T., Sankar, A., Marstrand-Joergensen, M. R., Ozenne, B., Osler, M., Penninx, B. W. J. H., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22623808
Tuncel, H., Boellaard, R., Coomans, E. M., Hollander-Meeuwsen, M. D., de Vries, E. F. J., Glaudemans, A. W. J. M., Feltes, P. K., García, D. V., Verfaillie, S. C. J., Wolters, E. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19029036
Additional file 1 of Evaluation of [11C]UCB-A positron emission tomography in human brains
Xiong, M., Lubberink, M., Appel, L., Fang, X. T., Danfors, T., Kumlien, E., & Antoni, G. (2024) · Figshare · doi:10.6084/m9.figshare.26735010
Wang, X., Zhang, X., Liu, J., Zhang, J., Liu, C., Cui, Y., Song, Q., Hou, Y., Wang, Y., Zhang, Q., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25599864
Husain, M. O., Jones, B. D. M., Arshad, U., Ameis, S. H., Mirfallah, G., Schifani, C., Rodak, T., Aiken, M., Shafique, M., Ahmed, F., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26066220
Tuncel, H., Boellaard, R., Coomans, E. M., Hollander-Meeuwsen, M. D., de Vries, E. F. J., Glaudemans, A. W. J. M., Feltes, P. K., García, D. V., Verfaillie, S. C. J., Wolters, E. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19029048
Jensen, K. H. R., Dam, V. H., Ganz, M., Fisher, P. M., Ip, C.-T., Sankar, A., Marstrand-Joergensen, M. R., Ozenne, B., Osler, M., Penninx, B. W. J. H., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22623805
O’Dell, R. S., Mecca, A. P., Chen, M.-K., Naganawa, M., Toyonaga, T., Lu, Y., Godek, T. A., Harris, J. E., Bartlett, H. H., Banks, E. R., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13525173
Self-citationVolpi, T., Maccioni, L., Colpo, M., Debiasi, G., Capotosti, A., Ciceri, T., Carson, R. E., DeLorenzo, C., Hahn, A., Knudsen, G. M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26638497
Self-citationTuncel, H., Boellaard, R., Coomans, E. M., Hollander-Meeuwsen, M. D., de Vries, E. F. J., Glaudemans, A. W. J. M., Feltes, P. K., García, D. V., Verfaillie, S. C. J., Wolters, E. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19029012
Coomans, E. M., Schoonhoven, D. N., Tuncel, H., Verfaillie, S. C. J., Wolters, E. E., Boellaard, R., Ossenkoppele, R., den Braber, A., Scheper, W., Schober, P. R., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13725141
Jensen, K. H. R., Dam, V. H., Ganz, M., Fisher, P. M., Ip, C.-T., Sankar, A., Marstrand-Joergensen, M. R., Ozenne, B., Osler, M., Penninx, B. W. J. H., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22623802
van Dyck, C. H., Mecca, A. P., O’Dell, R. S., Bartlett, H. H., Diepenbrock, N. G., Huang, Y. H., Hamby, M. E., Grundman, M., Catalano, S. M., Caggiano, A. O., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26672991
Self-citationHusain, M. O., Jones, B., Arshad, U., Ameis, S. H., Mirfallah, G., Schifani, C., Rodak, T., Aiken, M., Shafique, M., Ahmed, F., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26736453
Tuncel, H., Boellaard, R., Coomans, E. M., Hollander-Meeuwsen, M. D., de Vries, E. F. J., Glaudemans, A. W. J. M., Feltes, P. K., García, D. V., Verfaillie, S. C. J., Wolters, E. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19029006
Tuncel, H., Boellaard, R., Coomans, E. M., Hollander-Meeuwsen, M. D., de Vries, E. F. J., Glaudemans, A. W. J. M., Feltes, P. K., García, D. V., Verfaillie, S. C. J., Wolters, E. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19029015
Tuncel, H., Boellaard, R., Coomans, E. M., Hollander-Meeuwsen, M. D., de Vries, E. F. J., Glaudemans, A. W. J. M., Feltes, P. K., García, D. V., Verfaillie, S. C. J., Wolters, E. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19029027
Husain, M. O., Jones, B., Arshad, U., Ameis, S. H., Mirfallah, G., Schifani, C., Rodak, T., Aiken, M., Shafique, M., Ahmed, F., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26066140
Tuncel, H., Boellaard, R., Coomans, E. M., Hollander-Meeuwsen, M. D., de Vries, E. F. J., Glaudemans, A. W. J. M., Feltes, P. K., García, D. V., Verfaillie, S. C. J., Wolters, E. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19029042
Whiteside, D. J. (2023) · Apollo (University of Cambridge) · doi:10.17863/cam.105517
Goutal, S., Guillermier, M., Becker, G., Gaudin, M., Bramoullé, Y., Luxen, A., Lemaire, C. F., Plenevaux, A., Salmon, É., Hantraye, P., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14385090
Moors, T. E., Mona, D., Luehe, S., Duran-Pacheco, G., Spycher, L., Mundigl, O., Kaluza, K., Huber, S., Hug, M. N., Kremer, T., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19993861
Glorie, D., Verhaeghe, J., Miranda, A., Lombaerde, S. D., Stroobants, S. G., & Staelens, S. G. (2020) · Figshare · doi:10.6084/m9.figshare.13237747
Tuncel, H., Boellaard, R., Coomans, E. M., Hollander-Meeuwsen, M. D., de Vries, E. F. J., Glaudemans, A. W. J. M., Feltes, P. K., García, D. V., Verfaillie, S. C. J., Wolters, E. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19029063
van Dyck, C. H., Mecca, A. P., O’Dell, R. S., Bartlett, H. H., Diepenbrock, N. G., Huang, Y. H., Hamby, M. E., Grundman, M., Catalano, S. M., Caggiano, A. O., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26672994
Self-citationTuncel, H., Boellaard, R., Coomans, E. M., Hollander-Meeuwsen, M. D., de Vries, E. F. J., Glaudemans, A. W. J. M., Feltes, P. K., García, D. V., Verfaillie, S. C. J., Wolters, E. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19029009
Tuncel, H., Boellaard, R., Coomans, E. M., Hollander-Meeuwsen, M. D., de Vries, E. F. J., Glaudemans, A. W. J. M., Feltes, P. K., García, D. V., Verfaillie, S. C. J., Wolters, E. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19029030
Tuncel, H., Boellaard, R., Coomans, E. M., Hollander-Meeuwsen, M. D., de Vries, E. F. J., Glaudemans, A. W. J. M., Feltes, P. K., García, D. V., Verfaillie, S. C. J., Wolters, E. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19029060
Tuncel, H., Boellaard, R., Coomans, E. M., Hollander-Meeuwsen, M. D., de Vries, E. F. J., Glaudemans, A. W. J. M., Feltes, P. K., García, D. V., Verfaillie, S. C. J., Wolters, E. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19029054
Rossano, S. M., Toyonaga, T., Bini, J., Nabulsi, N., Ropchan, J. R., Cai, Z., Huang, Y. H., & Carson, R. E. (2022) · Figshare · doi:10.6084/m9.figshare.19703777
Self-citationWang, Y.-T., Ashton, N. J., Servaes, S., Nilsson, J., Woo, M. S., Pascoal, T. A., Tissot, C., Rahmouni, N., Therriault, J., Lussier, F. Z., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25910018
Alqahtani, M. M., Malik, M. M. U. D., & Shukla, A. K. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898813543125010016
Quantitative SPECT and PET: From Research to Clinical Practice
Lamghare, P. K., Malik, M. M. U. D., & Alqahtani, M. M. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898813543125010014
Pediatric Cortical Dysplasia: PET Studies
Jagadeesan, B., & Juhász, C. (2025) · Springer eBooks · doi:10.1007/978-3-031-95878-6_6
Detecting neuroplastic effects induced by ketamine in healthy human subjects: a multimodal approach
Agnorelli, C., Peill, J. M., Sawicka, G., Kurtin, D. L., Shatalina, E., Ahmad, K., Wall, M., Rua, C., Godfrey, K., Erl, N., et al. (2026) · Neuroscience Applied · doi:10.1016/j.nsa.2025.105744
Role of Molecular Imaging in Parkinson’s Disease
Su, D., & Stoessl, A. J. (2025) · Springer eBooks · doi:10.1007/978-3-031-95878-6_3
Restarting synaptic remodeling and structural network: New treatment strategies for epilepsy
Cao, L., Pan, C., Wang, X., Zhang, B., Zhang, Z., Yu, C., & Xu, Z. (2026) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00826
Redox‐aktivierte Sonden für Hochkontrastige Live‐Bildgebung Postsynaptischer Neuronaler Gerüste
Huhn, C., Mille, C., Ho, S., Lützenkirchen, F. P., Khayenko, V., Hein, M., Werner, C., Kneussel, M., Hell, J. W., Specht, C. G., et al. (2026) · Angewandte Chemie · doi:10.1002/ange.202519933
Yadav, T. C., Orsucci, I. C., Thompson, S. V., Wu, Z., Li, Z., Yuan, H., Yadav-Samudrala, B. J., & Fitting, S. (2026) · NeuroImmune Pharmacology and Therapeutics · doi:10.1515/nipt-2025-0020
“Positron emission tomography (PET) imaging of synaptic vesicle glycoprotein 2A (SV2A), a protein located in the presynaptic vesicle membrane, that is ubiquitously expressed in virtually all synapses [8, 9], has emerged as a robust, noninvasive method to quantify synaptic density in vivo [10–13].”
Do new neurons grow in the adult human hippocampus? A review of the evidence
Loumpourdi, M. (2026) · Exploration of neuroscience · doi:10.37349/en.2026.1006128
Neurovascular coupling dysfunction of the frontal‒thalamic circuit in postconcussion syndrome
Yan, J., Huang, W., Xu, L., Xu, K., Jiang, L., Chang, M., & Zhang, J. (2026) · Brain Imaging and Behavior · doi:10.1007/s11682-026-01119-9
“…showing impaired NVC co-localize with chronic neuroinflammation or reduced synaptic density in the same frontal–thalamic–hippocampal circuits (Carson et al., 2022 ; Finnema et al., 2016; Ramlackhansingh et al., 2011), thereby providing more specific biological validation of the present findings.”
Unsupervised anomaly detection on time series using SNN for lower computational costs
Cherdo, Y. (2024) · theses.fr (ABES) · doi:10.70675/32dbf1e1zb8f4z4586z9cdcz4b0032a1e919
Stress and synaptic density in psychosis and clinical high risk: evidence from [18F]SynVesT-1 PET
Blasco, M. B., Aji, K. N., Ramos-Jiménez, C., Chartrand, D. A., Hsiao, C. H.-H., Hopewell, R., Massarweh, G., Cohen, J., Rusjan, P., & Mizrahi, R. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-03993-9
“Speci fi cally, radioligands bind to synaptic vesicle glycoprotein 2 A (SV2A), which is ubiquitously expressed on nerve terminals throughout the brain, [11] and highly correlates with gold standard presynaptic markers (e.g., synaptophysin) [12].”
Li, Y., Zatcepin, A., Palumbo, G., Oos, R., Wind-Mark, K., Lindner, S., Gildehaus, F., Gnörich, J. S., Werner, R. A., Brendel, M., et al. (2026) · NeuroImage · doi:10.1016/j.neuroimage.2026.121932
Rollenhagen, A., Sadeghi, A., Walkenfort, B., Hilgetag, C. C., Sätzler, K., & Lübke, J. H. R. (2025) · eLife · doi:10.18154/rwth-2026-04086
Panichnantakul, P., Shaw, R., Burianova, V. K., McErlain, H., Sutherland, A., Williams, A., Waldman, A. D., & Tavares, A. A. S. (2026) · EJNMMI Research · doi:10.1186/s13550-026-01391-2
“The use of positron emission tomography (PET) radioligands targeting SV2A has enabled in vivo visualisation of synaptic alterations [4].”
Everix, L., Miranda, A., Akkermans, J., Khetarpal, V. K., Liu, L., Bard, J., Staelens, S. G., & Bertoglio, D. (2026) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x261435323
Automated GMP production and long-term experience in radiosynthesis of the SV2A tracer [11C]UCB-J
Wahlroos, S., Krzyczmonik, A., Helin, S., Rajander, J., Solin, O., & Kirjavainen, A. (2026) · EJNMMI Radiopharmacy and Chemistry · doi:10.1186/s41181-025-00377-0
“This radiotracer can also be used to measure drug binding to its target, and PET imaging of SV2A can be performed to characterize the binding of levetiracetam or other SV2A-targeting drugs (Finnema et al. 2016; Milicevic Sephton et al. 2020; Nabulsi et al. 2016).”
InfluentialMolecular Imaging and Theragnosis Using Radiopharmaceuticals
García-Varela, L., Núñez, V. P., & Aguiar, P. (2026) · Springer handbooks · doi:10.1007/978-3-032-01636-2_33
Estimation of SV2A PET-Derived Synaptic Density from Quantitative MRI Using Data-Driven Methods
Ruymaekers, A., Meyer, F., Huang, J., Jacquemin, A., Dauby, S., Salmon, É., Bastin, C., Phillips, C. L. M., Zubkov, M. A., & Bahri, M. A. (2026) · ORBi (University of Liège)
Transcriptomic signatures of synaptic loss in Alzheimer’s disease
Sun, L., Yang, X., Xu, X., Kang, L., Zheng, Y., Huang, Q., Xu, W., Guan, Y., Shen, Y., Liu, J. S., et al. (2026) · iScience · doi:10.1016/j.isci.2026.116336
“63,74 Third, AHBA transcriptomic data represent bulk RNA and lack single-cell resolution, 64 limiting cell-type precision.”
Basuli, F., Shi, J., Zhang, X., & Swenson, R. E. (2026) · Molecules · doi:10.3390/molecules31132396
Psilocybin’s effect on human brain synaptic plasticity
Johansen, A., Plavén‐Sigray, P., Madsen, M. K., Søndergaard, A., Messell, C., Geisler, M., Nasser, A., McCulloch, D. E.-W., Beliveau, V., Vassilieva, A., et al. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04285-y · Cited by 1
“SV2A can be quanti fi ed in vivo in the human brain using positron emission tomography (PET) with the tracer [ 11 C]UCB-J [26].”
Zhao, Y., Shen, B., Luo, W., & Wang, M. (2026) · Journal of Neurology · doi:10.1007/s00415-026-14026-2
“First-generation carbon-11-labeled ligands, primarily [ 11 C]UCB-J, demonstrate high efficacy in localizing the EZ but are logistically constrained by the 20-min physical half-life of the radionuclide [24, 25].”
Bu, J., Nie, X., Luo, H., Wang, J., Jiang, D., Xu, N., Zhuang, P., Zhang, Y., & Yin, Q. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108383
Detecting dementia and measuring progression
Spires‐Jones, T. L. (2026) · Oxford University Press eBooks · doi:10.1093/9780198995296.003.0005
Ito, H., Hosomi, S., Koyama, Y., Ogura, H., Watabe, T., Matsunaga, K., Naka, S., Kobayashi, Y., Kobayashi, H., Shimada, S., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-69148-4
Garrou, F., Leva, L., Sacchetti, G. M., de Natale, E. R., Tondo, G., & Comi, C. (2026) · Journal of Neurology · doi:10.1007/s00415-026-14123-2
“[ 11 C]UCB-J remains the most extensively studied SV2A PET ligand and has generated most of the available evidence in PD and Lewy body disorders, but its carbon-11 label limits dissemination to centers with on-site cyclotron infrastructure [10].”
Qiao, Z., Li, S., Zhang, Y., Zhao, X., Yang, Z., Sun, X., Chen, H., Cheng, X., Liu, Y., Ai, L., et al. (2026) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6c01052
Honhar, P., Tinaz, S., Sadabad, F. E., Gallezot, J., Naganawa, M., Dias, M., Ye, Y., Gao, H., Nabulsi, N., Huang, Y. H., et al. (2026) · medRxiv · doi:10.64898/2026.09.28.26364237
Self-citationRadiopharmaceuticals in Molecular Neuroimaging
Yokoyama, K., Franceschi, A. M., Chiang, G. C.-Y., Ishii, K., & Ito, K. (2026) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2026.07.009
Towards the synthesis of 18F-SV2A radiotracers
Qin, M. (2026) · ORCA Online Research @Cardiff (Cardiff University)
PET-based molecular imaging in neurodegeneration and dementia: current and emerging radiotracers
Gil, N., Naik, P., Koran, M. E., Silverman, D., Kako, B., & Chen, J. (2026) · Radiology Advances · doi:10.1093/radadv/umag046
“52 However, due to the short 20-min half-life of carbon-11 and inherently long scan times, 18 F-labeled tracers ( 18 F-SynVesT-1 and 18 F-SynVesT-2) were developed.”
Interpreting Lower Synaptic Vesicle Glycoprotein 2A Availability in Bipolar Disorder
Frangou, S. (2026) · Biological Psychiatry · doi:10.1016/j.biopsych.2026.07.018
Future Directions in Neurochemistry and Brain Disorders
Tripathi, P. N., Gangwar, M., Singh, N. K., Verma, V. C., Singh, J. K., & Marwaha, J. (2026) · Royal Society of Chemistry eBooks · doi:10.1039/9781837071395-00337
Neophytou, D. (2026) · CUNY Academic Works (City University of New York)
Mamat, M., Chen, Y., & Li, L. (2026) · Communications Biology · doi:10.1038/s42003-026-11166-z
Carron, C., Boeckxstaens, L., Degryse, L., Vanderlinden, G., Noë, S., Deckers, W., Schramm, G., Gijs, J., Vandenbulcke, M., Vandenberghe, R., et al. (2026) · Journal of Nuclear Medicine · doi:10.2967/jnumed.126.272646
Peter, D. C., McLachlan, M., DiFilippo, A. H., Yang, K. L., Pasquesi, M., Barnhart, T. E., Engle, J. W., Betthauser, T. J., Asthana, S., Johnson, S. C., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71900
“53,54 However, longitudinal studies are needed to understand the potentially unique temporal patterns of plasma β -synuclein and UCB-J PET across theADcontinuum.”
Koivumäki, M., Snellman, A., Ekblad, L. L., Benedet, A., Zetterberg, H., & Rinne, J. O. (2026) · Research Square · doi:10.21203/rs.3.rs-11294615/v1
A Comparison and Validation of BIDS Apps for Preprocessing of [ 11 C]UCB-J PET dataPreprint
Haver, G., Matheson, G. J., Yngwe, H., Andersson, M., Edvall, N. K., Noergaard, M., Zanderigo, F., Schmidt, M., Bartlett, E. A., Miller, J. M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.28.762181
Camastra, C., Uribe, C., Rosal, A. E., Chow, C., Coulombe, M. E., Murgoci, A., Quattrone, A., & Strafella, A. P. (2026) · Journal of Parkinson s Disease · doi:10.1177/1877718x261505655
Peñuelas, J., & Galiano-Landeira, J. (2026) · Biosystems · doi:10.1016/j.biosystems.2026.106003
Metadata
- Authors
- Finnema, S. J., Nabulsi, N. B., Eid, T., Detyniecki, K., Lin, S.-F., Chen, M.-K., Dhaher, R., Matuskey, D., Baum, E., Holden, D., Spencer, D. D., Mercier, J., Hannestad, J., Huang, Y., & Carson, R. E.
- Affiliations
- Yale University (US)
- UCB Pharma (Belgium) (BE)
- Corresponding author
- Finnema, Sjoerd J.
- Hannestad, Jonas
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2016-07-20
- Volume
- 8
- Issue
- 348
- Pages
- 348ra96-348ra96
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2503767557
- Cited by
- 575
- References
- 59
- Citations by year
- 2026: 52 · 2025: 70 · 2024: 81 · 2023: 54 · 2022: 92 · 2021: 67 · 2020: 54 · 2019: 43 · 2018: 23 · 2017: 31 · 2016: 6
- FWCI
- 29.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Swebilius Foundation
- UCB Pharma
- Swedish Research Council
- National Center for Advancing Translational Science (UL1 TR000142)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- synaptic density, SV2A, positron emission tomography, presynaptic terminals, synaptophysin, temporal lobe epilepsy, synaptic loss, Alzheimer's disease, neuroimaging
- MeSH terms
- Adult, Aged, Brain, Epilepsy, Female, Humans, Male, Membrane Glycoproteins, Middle Aged, Nerve Tissue Proteins, Synapses, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.